Splash

Investors

We are committed to delivering our strategy and creating value for our shareholders.
Splash
Investors
Latest Results

Latest Results

We’re pleased to announce our latest results.

Download Results

Latest News

Latest Events

November 9 2021Regulatory
Verona Pharma Reports Third Quarter 2021 Financial Results and Provides Corporate Update

Enrollment in ENHANCE-1 48-week subset and ENHANCE-2  expected to complete around year-end 2021 ENHANCE Phase 3 program on track to report top-line data in 2022 Conference call today at 9:00 a.m. EST / 2:00 p.m. GMT LONDON and RALEIGH, N.C., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Verona Pharma plc

November 1 2021Regulatory
Verona Pharma Announces November 2021 Investor Conference Participation

LONDON and RALEIGH, N.C., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that David Zaccardelli, Pharm. D., President and Chief Executive Officer, will present at the

October 26 2021Regulatory
Verona Pharma to Report Third Quarter 2021 Financial Results and Provide Corporate Update

LONDON and RALEIGH, N.C., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that it will report its financial results for the three and nine months ended September 30, 2021 on

View all regulatory news
Splash

© Verona Pharma plc 2021. All rights reserved